Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
06/2003
06/26/2003WO2002046385A3 Enzymes
06/26/2003WO2002016597A3 Lipid metabolism enzymes
06/26/2003US20030120079 Such as 7-((R)-2-((E)-3-(3-Benzyl-phenyl)-3-hydroxy-propenyl)-5-oxo-pyrrolidin-1-yl)-heptanoic acid; side effects reduction
06/26/2003US20030120059 Cell surface molecule-induced macrophage activation
06/26/2003US20030119916 Treatment of functional gastrointestinal disorders
06/26/2003US20030119902 Novel aminobenzoephenones
06/26/2003US20030119898 6-96 mu g of a 7-hydroxy-cyclopenta-3-one(b)pyran derivatives
06/26/2003US20030119878 A 1-arylalkyl-3-aminoalkyl-1,4-dihydropyrid-4-one derivative; sexual disorders; anticarcinogenic agents; benign prostatic hypertrophy/fibroids of the uterus; endometriosis, polycystic ovarian disease, precocious puberty; contraceptives
06/26/2003US20030119869 1-(Piperidin-4-yl)benzimidazole or -triazole derivatives; agonists and antagonist for beta-chemokine (chemotactic cytokines) receptors; viricides; HIV; antiarthritic agents; atherosclerosis, psoriasis, antiallergens; multiple sclerosis
06/26/2003US20030119845 4-((4-benzyl(or methyl heteroaryl)-,1-piperazinyl)(8-quinolinyl)methyl)-N,N-diethylbenzamide or salt, useful for pain treatment
06/26/2003US20030119844 Bind with high selectivity and/ or high affinity to CRF1 receptors (Corticotropin Releasing Factor 1 Receptors), useful for treating psychiatric and neurological diseases, including depression, anxiety and post trauma stress
06/26/2003US20030119842 Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines
06/26/2003US20030119840 4-Heteroparyl-1,4-diazabicyclo[3.2.2]nonane, preparation and therapeutic use thereof
06/26/2003US20030119838 Water-soluble phenylpyridazine compounds and compositions containing the same
06/26/2003US20030119837 Pharmaceutical composition for the treatment of CNS and other disorders
06/26/2003US20030119835 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents
06/26/2003US20030119830 Monocyte chemoattractant protein-1 inhibitor compounds
06/26/2003US20030119829 4-amino-5,6-substituted thiopheno [2,3-d] pyrimidines, pharmaceutical compositions containing the same, and their use in the treatment or prevention of PDE7B-mediated diseases and conditions
06/26/2003US20030119827 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases
06/26/2003US20030119824 Treatment of inflammatory bowel disease
06/26/2003US20030119822 Bridged bicyclic amino acid-derived [1,4]benzodiazepine vasopressin receptor antagonists
06/26/2003US20030119820 Substituted indoles
06/26/2003US20030119818 CRF antagonistic quino-and quinazolines
06/26/2003US20030119810 Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation
06/26/2003US20030119797 Methods for selective immunomodulation
06/26/2003US20030119793 CAK inhibitors and uses thereof
06/26/2003US20030119792 Azo derivatives of 5-aminosalicylic acid containing an imidazolo(4,5-c)pyridine ring
06/26/2003US20030119786 Combinations for the treatment of immunoinflammatory disorders
06/26/2003US20030119784 Treating and preventing diarrhea and scours
06/26/2003US20030119758 An amine salt of (1-O-(4-(3,4-dimethoxyphenyl)-2-(3-ethylpentanoyl)-5,6,7-trimethoxy-3 -(methoxycarbonyl)naphthalen - 1-yl)-beta-D-glucopyranoside)uronic acid.
06/26/2003US20030119748 Use for treatment of inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury.
06/26/2003US20030119724 Contain a hepatic ligand to direct an oligomer or "payload" to a hepatocyte intracellularly via a receptor-mediated, ligand-directed pathway; solid phase synthesis
06/26/2003US20030119715 Prevent retinoid binding; antiaging agents; activation cell differentiation
06/26/2003US20030119111 G-protein coupled receptor, named 2871 receptor
06/26/2003US20030119095 Novel nucleic acid sequences encoding human vesicle transport protein-like and residue rat-like polypeptides
06/26/2003US20030119076 B7-like polynucleotides, polypeptides, and antibodies
06/26/2003US20030118669 Novel substituted benzimidazole dosage forms and method of using same
06/26/2003US20030118650 Tableted oral pharmaceutical dosage form, with enteric coating, containing a compound of benzimidazole labile in an acid medium
06/26/2003US20030118577 Use of analogues of superoxide dismutase for treating hepatocellular insufficiencies
06/26/2003US20030118575 Administering a pyrazole compound containing urea or thiourea groups, twice daily to a patient in need of treatment of a cytokine mediated disease
06/26/2003US20030118571 Oral administration of lactobacillus for the maintenance of health in women during pregnancy and at other life stages, to reduce the risk of urogenital diseases
06/26/2003US20030118536 Topical compositions and methods for treatment of adverse effects of ionizing radiation
06/26/2003US20030118507 Methods of using 46828, a human acyl-CoA synthetase
06/26/2003CA2473938A1 Human adam-10 inhibitors
06/26/2003CA2473877A1 Substituted beta-aminoalcohols as pharmaceutical preparations
06/26/2003CA2471777A1 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
06/26/2003CA2471500A1 Substituted 1,5-diaminopentan-3-ol compounds
06/26/2003CA2470723A1 3,4-dihydro-1h-isoquinolin-2-yl-derivatives
06/26/2003CA2470616A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
06/26/2003CA2470236A1 Lactams as tachykinin antagonists
06/26/2003CA2469950A1 Methods for treatment or prophylaxis of aldosterone-mediated pathogenic effectgs in a subject using an epoxy-steroidal aldosterone antagonist
06/26/2003CA2469944A1 Medicaments comprising n, n'-disubstituted piperazine compounds and their use
06/26/2003CA2469785A1 Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor
06/26/2003CA2469048A1 Quinolinones as prostaglandin receptor ligands
06/26/2003CA2468690A1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
06/26/2003CA2468688A1 New process
06/26/2003CA2468687A1 Liquid bisphosphonate formulations for bone disorders
06/26/2003CA2468448A1 Benzodiazepine derivatives, preparation thereof and use thereof
06/26/2003CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003CA2465888A1 Topical compositions and methods for treatment of adverse effects of ionizing radiation
06/26/2003CA2446292A1 Nucleic acid-associated proteins
06/25/2003EP1321476A2 Binding protein
06/25/2003EP1321461A1 N-(Cyclopropylmethyl)-azacycloalkanes, compositions containing them and methods for their preparation
06/25/2003EP1321169A1 Combination of a serotonin receptor antagonist with a histidine decarboxylase inhibitor as a medicament
06/25/2003EP1321142A1 Solid pharmaceutical composition for oral administration of Tegaserod
06/25/2003EP1320710A1 Drying method for selectively removing volatile components from wet coatings
06/25/2003EP1320614A2 Novel proteases
06/25/2003EP1320600A1 Transporters and ion channels
06/25/2003EP1320551A1 The identification and development of specific monoclonal antibodies to squamous cell carcinoma
06/25/2003EP1320550A2 G-protein coupled receptors
06/25/2003EP1320548A2 Transporters and ion channels
06/25/2003EP1320545A2 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen
06/25/2003EP1320540A2 Peptidomimetic protease inhibitors
06/25/2003EP1320521A1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(en)oic acid as therapeutic agents
06/25/2003EP1320520A1 Sulfonylguanidine
06/25/2003EP1320365A1 Substituted azole derivatives as inhibitors of corticotropin releasing factor
06/25/2003EP1320363A1 Lactone integrin antagonists
06/25/2003EP1200442B1 2,3-benzodiazepine derivatives
06/25/2003EP1178981B1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
06/25/2003EP1112692B1 Drinks and foods capable of eliminating helicobacter pylori
06/25/2003EP1019036B1 Use of d-methionine to reduce the toxicity of ototoxic drugs and noise
06/25/2003EP0938282B1 Preparation for dental treatment
06/25/2003EP0874824B1 Tri-substituted phenyl derivatives useful as pde iv inhibitors
06/25/2003EP0840615B1 Chemokine binding protein and methods of use therefor
06/25/2003EP0668879B1 Truncated insulin-like growth factor binding proteins having mitogenic activity
06/25/2003CN1426421A Tumour-specific animal proteins
06/25/2003CN1426414A Prodrugs of imidazopyridine derivatives
06/25/2003CN1426412A Novel compounds
06/25/2003CN1426411A 3-(diarylmethylene)-8-azabicyclo [3,2,1] octane derivatives
06/25/2003CN1426406A Process for producing optically active sulfoxide devivative'
06/25/2003CN1426405A 新型环状酰胺衍生物 Novel cyclic amide derivative
06/25/2003CN1426396A Substituted benzoic acid amides and use for inhibition of angiogenesis thereof
06/25/2003CN1426394A Novel compounds
06/25/2003CN1426393A Novel compounds
06/25/2003CN1426392A Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same
06/25/2003CN1426310A Medicinal compositions promoting bowel movement
06/25/2003CN1425753A Brewing process and pecipe for scorpion-ant health wine
06/25/2003CN1425680A Nucleotide analogue composition and preparing method
06/25/2003CN1425652A Aporphine alkaloids with hepatitis virus inhibiting activity
06/25/2003CN1425651A Tegaserod maleate-water crystal
1 ... 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 ... 1258